Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen C Dreskin

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Immunology and Allergy Clinics of North America|May 4, 2004
Urticaria and angioedema: an overviewDonald A Dibbern, Stephen C Dreskin
Primary Care|January 22, 2008
UrticariaSheila M Amar, Stephen C Dreskin
Current Allergy and Asthma Reports|July 4, 2013
Urticaria and autoimmunity: where are we now?Jenny M Stitt, Stephen C Dreskin
Immunotherapy|September 5, 2014
The potential role of omalizumab in the treatment of chronic urticariaJenny M Stitt, Stephen C Dreskin
Frontiers in Allergy|April 7, 2022
The Effector Function of AllergensStéphane Hazebrouck, Nicole Canon, Stephen C Dreskin
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 2, 2025
Total IgE as a Biomarker of Response to Omalizumab in Chronic Urticaria: A Prospective StudyLevi Keller, Jenny M Stitt, Stephen C Dreskin
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 3, 2011
Analysis of anaphylaxis cases after vaccination: 10-year review from the National Vaccine Injury Compensation ProgramRosemary Johann-Liang, Shelby Josephs, Stephen C Dreskin
The Journal of Allergy and Clinical Immunology|May 14, 2003
A possible role for cyclooxygenase 2 inhibitors in the treatment of chronic urticariaMiriam K Anand, Harold S Nelson, Stephen C Dreskin
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 5, 2013
Implementing standardized intravenous antibiotic desensitizations among hospital inpatientsAmy C Go, Gerard R Barber, Stephen C Dreskin
Allergy and Asthma Proceedings|April 24, 2008
Mediator measurements after daily instillation of allergen: Increased IL-5 and decreased IFN-gammaRobert A McDermott, Harold S Nelson, Stephen C Dreskin
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Immunology and Allergy Clinics of North America|May 4, 2004
Urticaria and angioedema: an overviewDonald A Dibbern, Stephen C Dreskin
Primary Care|January 22, 2008
UrticariaSheila M Amar, Stephen C Dreskin
Current Allergy and Asthma Reports|July 4, 2013
Urticaria and autoimmunity: where are we now?Jenny M Stitt, Stephen C Dreskin
Immunotherapy|September 5, 2014
The potential role of omalizumab in the treatment of chronic urticariaJenny M Stitt, Stephen C Dreskin
Frontiers in Allergy|April 7, 2022
The Effector Function of AllergensStéphane Hazebrouck, Nicole Canon, Stephen C Dreskin
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 2, 2025
Total IgE as a Biomarker of Response to Omalizumab in Chronic Urticaria: A Prospective StudyLevi Keller, Jenny M Stitt, Stephen C Dreskin
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 3, 2011
Analysis of anaphylaxis cases after vaccination: 10-year review from the National Vaccine Injury Compensation ProgramRosemary Johann-Liang, Shelby Josephs, Stephen C Dreskin
The Journal of Allergy and Clinical Immunology|May 14, 2003
A possible role for cyclooxygenase 2 inhibitors in the treatment of chronic urticariaMiriam K Anand, Harold S Nelson, Stephen C Dreskin
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 5, 2013
Implementing standardized intravenous antibiotic desensitizations among hospital inpatientsAmy C Go, Gerard R Barber, Stephen C Dreskin
Allergy and Asthma Proceedings|April 24, 2008
Mediator measurements after daily instillation of allergen: Increased IL-5 and decreased IFN-gammaRobert A McDermott, Harold S Nelson, Stephen C Dreskin
Pageof 7